Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

NCT00718159 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Essential Thrombocythemia

Interventions

DRUG: LY573636-sodium

Sponsor

Eli Lilly and Company